M. Alexander Otto, PA, MMS

News

Does surgery improve survival in metastatic breast cancer?

Author:: M. Alexander Otto, PA, MMS

Publish date: October 9, 2023

“The analysis revealed no overall survival benefit for patients who underwent surgical excision of their primary breast tumor.”

News

CT simulation not needed in palliative radiotherapy planning

Author:: M. Alexander Otto, PA, MMS

Publish date: October 5, 2023

“Diagnostic CT-based radiation planning substantially reduces time in the [treatment] center without a detriment in plan deliverability or quality....

News

Cost concerns lead to cancer treatment delays, nonadherence

Author:: M. Alexander Otto, PA, MMS

Publish date: September 29, 2023

Hospital-based financial navigators may help cancer patients negotiate the intricacies of insurance coverage, experts suggest.

News

FDA approves bosutinib for children with CML

Author:: M. Alexander Otto, PA, MMS

Publish date: September 28, 2023

Bosutinib, a tyrosine kinase inhibitor, has been approved by the FDA for treatment of child patients with chronic myelogenous leukemia.

News

Older women who get mammograms risk overdiagnosis

Author:: M. Alexander Otto, PA, MMS

Publish date: September 26, 2023

The proportion of older women who continue to receive screening mammograms and may experience breast cancer overdiagnosis is “considerable” and “in...

News

FDA approves JAK inhibitor momelotinib for myelofibrosis with anemia

Author:: M. Alexander Otto, PA, MMS

Publish date: September 18, 2023

Momelotinib is the fourth JAK inhibitor approved by the FDA to treat the anemia that often accompanies myelofibrosis, a rare form of blood cancer.<...

News

FDA approves motixafortide for stem cell mobilization in myeloma

Author:: M. Alexander Otto, PA, MMS

Publish date: September 11, 2023

Motixafortide has been approved by the FDA to help mobilize hematopoietic stem cells in autologous transplants for patients with multiple myeloma.<...

News

Delaying palliative chemo may improve QoL without affecting survival for asymptomatic patients

Author:: M. Alexander Otto, PA, MMS

Publish date: August 31, 2023

For asymptomatic patients, delaying the start of systemic therapy should be discussed with the patient.

News

Liver transplant in CRC: Who might benefit?

Author:: M. Alexander Otto, PA, MMS

Publish date: August 16, 2023

“It seems likely that there is a small group of patients with unresectable colorectal liver metastases who should be considered for transplant, and...

News

Scalp cooling for chemo hair loss strikes out with patients

Author:: M. Alexander Otto, PA, MMS

Publish date: August 9, 2023

“The efficacy and tolerability of [scalp cooling] applied in a clinical routine setting ... appeared to be limited.”

News

Cancer diagnoses, care access rise after Medicaid expansion

Author:: M. Alexander Otto, PA, MMS

Publish date: August 3, 2023

In Ohio, researchers found a substantial increase in diagnoses for all three cancers among Medicaid patients after expansion.

News

FDA OKs dostarlimab plus chemo for endometrial cancer

Author:: M. Alexander Otto, PA, MMS

Publish date: August 1, 2023

The trial results “and today’s approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-onco...

News

MRI-guided SBRT cuts radiation toxicity in prostate cancer

Author:: M. Alexander Otto, PA, MMS

Publish date: July 26, 2023

“These findings suggest that the technical advantages in precision of radiotherapy delivery afforded by MRI-guided SBRT translate to measurable cli...

News

Routine thromboprophylaxis for advanced ovarian cancer?

Author:: M. Alexander Otto, PA, MMS

Publish date: July 24, 2023

“Two-thirds [of VTEs] may have been preventable” because they occurred between epithelial ovarian cancer diagnosis and interval cytoreductive surge...

News

Palliative radiation therapy improves QoL in high-grade glioma

Author:: M. Alexander Otto, PA, MMS

Publish date: July 24, 2023

“Short-course palliative hypofractionated radiotherapy in patients with poor-prognosis [high-grade glioma] does not impair QoL in the short term.”<...